Sökning: id:"swepub:oai:DiVA.org:kth-315699" >
Repositioning of An...
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
-
- Kori, Medi (författare)
- Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
-
- Arga, Kazim Yalcin (författare)
- Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.;Marmara Univ, Genet & Metab Dis Res & Invest Ctr GEMHAM, Istanbul, Turkey.
-
- Mardinoglu, Adil (författare)
- KTH,Science for Life Laboratory, SciLifeLab,Systembiologi,Kings Coll London, Fac Dent, Ctr Host Microbiome Interact, Oral & Craniofacial Sci, London, England.
-
visa fler...
-
- Turanli, Beste (författare)
- Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
-
visa färre...
-
Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.;Marmara Univ, Genet & Metab Dis Res & Invest Ctr GEMHAM, Istanbul, Turkey. (creator_code:org_t)
- 2022-06-13
- 2022
- Engelska.
-
Ingår i: Frontiers in Pharmacology. - : Frontiers Media SA. - 1663-9812. ; 13
- Relaterad länk:
-
https://doi.org/10.3...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Cervical cancer is the fourth most commonly diagnosed cancer worldwide and, in almost all cases is caused by infection with highly oncogenic Human Papillomaviruses (HPVs). On the other hand, inflammation is one of the hallmarks of cancer research. Here, we focused on inflammatory proteins that classify cervical cancer patients by considering individual differences between cancer patients in contrast to conventional treatments. We repurposed anti-inflammatory drugs for therapy of HPV-16 and HPV-18 infected groups, separately. In this study, we employed systems biology approaches to unveil the diagnostic and treatment options from a precision medicine perspective by delineating differential inflammation-associated biomarkers associated with carcinogenesis for both subtypes. We performed a meta-analysis of cervical cancer-associated transcriptomic datasets considering subtype differences of samples and identified the differentially expressed genes (DEGs). Using gene signature reversal on HPV-16 and HPV-18, we performed both signature- and network-based drug reversal to identify anti-inflammatory drug candidates against inflammation-associated nodes. The anti-inflammatory drug candidates were evaluated using molecular docking to determine the potential of physical interactions between the anti-inflammatory drug and inflammation-associated nodes as drug targets. We proposed 4 novels anti-inflammatory drugs (AS-601245, betamethasone, narciclasin, and methylprednisolone) for the treatment of HPV-16, 3 novel drugs for the treatment of HPV-18 (daphnetin, phenylbutazone, and tiaprofenoic acid), and 5 novel drugs (aldosterone, BMS-345541, etodolac, hydrocortisone, and prednisolone) for the treatment of both subtypes. We proposed anti-inflammatory drug candidates that have the potential to be therapeutic agents for the prevention and/or treatment of cervical cancer.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- inflammation
- drug repurposing
- anti-inflammatory drugs
- cervical cancer
- human papillomavirus 16
- human papillomavirus 18
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas